Hot melt patch and preparation method thereof
By optimizing the matrix ratio and additives of the hot melt patch of non-steroidal anti-inflammatory drugs, the problems of drug release instability and adhesion reduction of existing patches under high temperature conditions are solved, and thermal stability and adhesion performance are achieved The improvement ensures the stable release of the drug and a good user experience.
Patent Information
- Application Number
- CN202311201211.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-09-18
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-09-18
AI Technical Summary
The changes in drug release rate, the phenomenon of gel surface flow and the decrease in adhesion of existing non-steroidal anti-inflammatory patches under high temperature conditions affect the efficacy and user experience.
Using hot melt patches composed of styrene-isoprene-styrene triblock copolymer, polyisobutene, tackifier and plasticizer, to improve adhesion performance and heat by optimizing matrix ratio and additive use Stability, avoid residual glue and overflow.
It achieves excellent thermal stability and adhesion properties of non-steroidal anti-inflammatory hot-melt patches, ensuring stable drug release and good user experience.
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medical preparations, and particularly relates to a hot-melt patch and a preparation method thereof. Background Art
[0002] The transdermal drug delivery system is the third largest drug delivery system after oral administration and injection. It can deliver drugs into the human body's systemic blood system through the human epidermis and dermis to achieve local treatment of the affected area. Topical patches are the most common route of administration in transdermal drug delivery systems. Nonsteroidal anti-inflammatory drugs have antipyretic, analgesic, and anti-inflammatory effects and have been made into topical analgesics. Currently on the market are flurbiprofen patches, ketoprofen patches, loxoprofen sodium patches, etc.
[0003] Existing patch products often have the following problems: First, the drug release rate of the patch changes significantly under high temperature conditions, which may affect the efficacy, increase the incidence of adverse reactions, and even cause safety incidents; second, the adhesive surface of the patch is prone to flow during the placement process (glue overflows at the edge), resulting in a black adhesive ring on the skin when the patch is used, affecting the user experience; third, the adhesion of the patch decreases during the placement process, resulting in loose adhesion, affecting the patient's use effect. Summary of the invention
[0004] One of the purposes of the present invention is to provide a non-steroidal anti-inflammatory drug hot-melt patch with excellent thermal stability.
[0005] The second object of the present invention is to provide a method for preparing the hot-melt patch with excellent thermal stability, which is simple, feasible and easy to industrialize.
[0006] According to one aspect of the present invention, there is provided a hot melt patch, the patch comprising a backing layer, an adhesive layer and a protective layer, wherein the adhesive layer comprises, by weight percentage:
[0007] Active ingredient of the drug 1~10%,
[0008] Styrene-isoprene-styrene triblock copolymer 10~30%,
[0009] Polyisobutylene 8~20%,
[0010] Thickener 8~25%,
[0011] Plasticizer 20~70%,
[0012] The active ingredient of the medicine is a non-steroidal anti-inflammatory drug, and the weight ratio of styrene to isoprene in the styrene-isoprene-styrene triblock copolymer is 15 / 85 to 25 / 75.
[0013] Furthermore, in the hot-melt patch, the adhesive layer comprises, by weight percentage:
[0014] Active pharmaceutical ingredient 1~7%,
[0015] Styrene-isoprene-styrene triblock copolymer 15~25%,
[0016] Polyisobutylene 10~15%,
[0017] Thickener 10~20%,
[0018] Plasticizer 30~60%.
[0019] Furthermore, the melt index of the styrene-isoprene-styrene triblock copolymer is ≤20 g / 10 min.
[0020] Furthermore, the tackifier is hydrogenated rosin glycerol ester.
[0021] Furthermore, the softening point of the hydrogenated rosin glycerol ester is 80-120°C.
[0022] Furthermore, the non-steroidal anti-inflammatory drug is selected from at least one of loxoprofen or a pharmaceutically acceptable salt thereof, flurbiprofen or a pharmaceutically acceptable salt thereof, ketoprofen or a pharmaceutically acceptable salt thereof, diclofenac or a pharmaceutically acceptable salt thereof, and indomethacin or a pharmaceutically acceptable salt thereof.
[0023] Furthermore, the plasticizer is selected from at least one of liquid paraffin, peanut oil and olive oil.
[0024] Furthermore, the hot-melt patch further comprises at least one of a stabilizer, an antioxidant, a penetration enhancer, a pH adjuster, an anti-irritant, and a solubility enhancer.
[0025] Furthermore, the stabilizer is silicon dioxide, and the amount used is 0.2-3% by weight, and more preferably 0.5-2% by weight.
[0026] According to another aspect of the present invention, there is also provided a method for preparing the above-mentioned hot-melt patch, comprising the following steps:
[0027] Heat and melt the styrene-isoprene-styrene triblock copolymer, polyisobutylene, tackifier and part of the plasticizer, optionally add an antioxidant, stir evenly, then add the active ingredient and the remaining plasticizer, optionally add a cosolvent, a pH adjuster, an anti-irritant, a penetration enhancer and a stabilizer, stir evenly to obtain a paste;
[0028] The paste is evenly coated on the protective layer, then laminated to the backing layer, and finally cut into a suitable size to obtain a hot-melt patch.
[0029] Beneficial effects of the present invention:
[0030] The non-steroidal anti-inflammatory drug hot-melt patch of the present invention is prepared by selecting a matrix styrene-isoprene-styrene triblock copolymer, so that the patch has good adhesion performance, is easy to peel, has good thermal stability, and has no residual glue and glue overflow when attached to the skin.
[0031] The preparation method of the non-steroidal anti-inflammatory drug hot-melt patch with excellent thermal stability is simple, feasible and easy to industrialize. DETAILED DESCRIPTION
[0032] The invention provides a hot-melt patch, comprising a backing layer, an adhesive layer and a protective layer. The adhesive layer comprises, by weight percentage, 1-10% of a drug active ingredient, 10-30% of a styrene-isoprene-styrene triblock copolymer, 8-20% of polyisobutylene, 8-25% of a tackifier and 20-70% of a plasticizer. The drug active ingredient is a non-steroidal anti-inflammatory drug, and in the styrene-isoprene-styrene triblock copolymer, the weight ratio of styrene / isoprene is 15 / 85-25 / 75.
[0033] In the present invention, styrene-isoprene-styrene triblock copolymer and polyisobutylene are used as the matrix of the patch, and styrene-isoprene-styrene triblock copolymer (SIS) refers to a block copolymer of styrene and isoprene, and polystyrene is contained at both ends. Such styrene-isoprene-styrene block copolymers include Kraton D1111, D1113, D1114, D1124, D1126, D1161, D1163, D1164 or Baling Petrochemical 1105, 1106, 1209, 1124, 1126, 4019, 1125, 1128, 1108, 4016, etc. or JSR SIS5002, SIS5229, SIS5250, SI5403, SIS5506, etc. The present invention unexpectedly found that when the weight ratio of styrene / isoprene in the matrix is in the range of 15 / 85 to 25 / 75, the thermal stability of the patch is better. It is further found that when the melt index of the styrene-isoprene-styrene triblock copolymer is ≤20g / 10min, the thermal stability is further improved, and there is no residual glue or overflowing glue when attached to the skin.
[0034] The hot-melt patch of the present invention preferably comprises, by weight percentage, the following components of the adhesive layer: 1-7% of the active pharmaceutical ingredient, 15-25% of the styrene-isoprene-styrene triblock copolymer, 10-15% of the polyisobutylene, 10-20% of the tackifier, and 30-60% of the plasticizer.
[0035] The tackifier of the present invention is preferably a rosin-based resin with rosin or rosin derivatives as the matrix. The rosin-based resin has a variety of models to choose from according to its source and processing method, such as KR-610, KR-614, KE604, KR-120, KE-100, KE-311, KE-359, and ESTERGUNM of Arakawa Chemical. The present invention finds that the softening point of the tackifier will affect the stability of the product. When a tackifier with a low softening point (<80°C) is used, the thermal stability of the prepared patch is poor, and glue overflow will occur, and there will be residue on the skin after application. When a tackifier with a high softening point (>120°C) is used, the prepared patch is not conducive to subsequent processing. Therefore, the present invention preferably uses hydrogenated rosin glycerol ester with a softening point of 80~120°C as an adhesive, which further improves the thermal stability of the hot-melt patch.
[0036] In the present invention, the active ingredient of the drug is a non-steroidal anti-inflammatory drug, which has antipyretic, analgesic, anti-inflammatory and other effects and has been made into analgesics for external use. A variety of non-steroidal anti-inflammatory drugs for external use have been marketed. The types of non-steroidal anti-inflammatory drugs in the present invention are not limited, and any non-steroidal anti-inflammatory drug that can be made into a hot-melt patch is applicable, preferably at least one of loxoprofen or a pharmaceutically acceptable salt thereof, flurbiprofen or a pharmaceutically acceptable salt thereof, ketoprofen or a pharmaceutically acceptable salt thereof, diclofenac or a pharmaceutically acceptable salt thereof, and indomethacin or a pharmaceutically acceptable salt thereof.
[0037] The plasticizer of the present invention can be selected from materials having good compatibility with other matrix components, such as liquid paraffin, peanut oil, olive oil, etc. One or more kinds of plasticizers can be used in combination, and liquid paraffin is particularly preferred.
[0038] Preferably, the hot-melt patch of the present invention may also include some conventionally used additives, such as stabilizers, antioxidants, penetration enhancers, pH regulators, anti-irritants, solubilizers, etc. The amounts of these additives are added according to actual needs. Generally, the amount of stabilizers is 0-3%, the amount of antioxidants is 0-2%, the amount of penetration enhancers is 0-3%, the amount of pH regulators is 0-2%, the amount of anti-irritants is 0-3%, and the amount of solubilizers is 0-10%. Furthermore, the antioxidant is preferably at least one of butylated hydroxytoluene, tocopherol acetate, propyl gallate, etc.; the penetration enhancer is preferably at least one of crotamiton, azone, menthol, N-methylpyrrolidone, oleic acid, eucalyptus oil, isopropyl myristate, etc.; the pH adjuster is preferably at least one of lactic acid, tartaric acid, citric acid, phosphoric acid, etc.; the anti-irritant is preferably at least one of L-menthol, menthol, peppermint oil, capsaicin, pepper extract, etc.; the cosolvent is selected from at least one of dimethyl sulfoxide (DMSO), propylene glycol, 1,3-butylene glycol; the stabilizer is selected from silicon dioxide, zinc stearate, etc.
[0039] The present invention unexpectedly found that when silicon dioxide is added as a stabilizer in a hot-melt patch, the thermal stability of the patch is further improved. The principle may be that small silicon dioxide particles form a grid structure in the patch matrix, which can inhibit the flow of colloids, thereby improving the elastic modulus and viscosity modulus of the pressure-sensitive adhesive, and can enhance the cohesion of the colloid, thereby improving the thermal stability of the patch. In terms of weight percentage, the amount of stabilizer silicon dioxide is 0.2-3%, preferably 0.5-2%.
[0040] The material used for the backing layer of the patch of the present invention is preferably a film or cloth such as polyester, polyethylene, polypropylene, polybutylene, nylon, polyurethane, etc.; the protective layer is preferably a pre-treated detachable release paper or a film such as polyethylene, polypropylene, polyester, etc.
[0041] According to another aspect of the present invention, there is also provided a method for preparing the above-mentioned hot-melt patch, comprising the following steps:
[0042] Heat and melt the styrene-isoprene-styrene triblock copolymer, polyisobutylene, tackifier and part of the plasticizer, optionally add an antioxidant, stir evenly, then add the active ingredient and the remaining plasticizer, optionally add a cosolvent, a pH adjuster, an anti-irritant, a penetration enhancer and a stabilizer, stir evenly to obtain a paste;
[0043] The paste is evenly coated on the protective layer, then laminated to the backing layer, and finally cut into a suitable size to obtain a hot-melt patch.
[0044] The following is a further detailed description of the present application by taking the active pharmaceutical ingredient selected from loxoprofen sodium, flurbiprofen and diclofenac sodium as an example. The following examples are only used to further illustrate the present application and should not be construed as limiting the present application.
[0045] The reagents and raw materials used in the present invention are all commercially available.
[0046] Table 1. SIS technical characteristics parameters.
[0047] .
[0048] Table 2. Softening points of hydrogenated rosin glycerol esters.
[0049] .
[0050] Examples 1 to 8 are loxoprofen sodium patches, and the prescriptions are shown in Table 3 below.
[0051] Table 3 List of prescriptions for various examples.
[0052] .
[0053] The preparation methods of Examples 1 to 8 are:
[0054] According to the proportion of the components, SIS, polyisobutylene, hydrogenated rosin glycerol ester, and part of the liquid paraffin are heated and melted, butylated hydroxytoluene is optionally added, stirred evenly, loxoprofen sodium and the remaining amount of liquid paraffin are added, and silicon dioxide, phosphoric acid, and menthol are optionally added, stirred evenly, to obtain a paste;
[0055] The paste is evenly coated on the protective layer, and then laminated to the backing layer, and finally cut into a suitable size to obtain the loxoprofen sodium patch.
[0056] The prescription of comparative example is shown in the following table.
[0057] Table 4 List of prescriptions for each comparative example.
[0058] .
[0059] The preparation methods of Comparative Examples 1 to 5 are:
[0060] According to the proportion of the components, SIS, polyisobutylene, hydrogenated rosin glycerol ester, and part of liquid paraffin are heated and melted, butylated hydroxytoluene is added, and stirred evenly, and then loxoprofen sodium, the remaining amount of liquid paraffin, silicon dioxide, phosphoric acid, and menthol are added, and stirred evenly to obtain a paste;
[0061] The paste is evenly coated on the protective layer, and then laminated to the backing layer, and finally cut into a suitable size to obtain the loxoprofen sodium patch.
[0062] Adhesion test
[0063] The loxoprofen sodium patches prepared in Examples 1 to 8 of the present invention and Comparative Examples 1 to 5 were tested according to the following method.
[0064] Take this product, cut it into 5cm×10cm size, and stick it on the inclined surface of the adhesion tester with the adhesive surface facing up, keeping no gap between it and the thick paper. Set the part above the inclined surface that is more than 10cm away from the test product as the center of the ball, and operate according to the law (Chinese Pharmacopoeia 2015 Edition Part Four General Rules 0952 First Method). When the protective layer is quickly torn off, record the largest ball number that the adhesive surface can prevent from falling. Repeat the test 3 times, and the largest ball number that the adhesive surface can prevent from falling should be 19 or more.
[0065] Table 5 Initial adhesion test results of various embodiments and comparative examples.
[0066] .
[0067] Thermal stability test
[0068] The loxoprofen sodium patches prepared in Examples 1 to 8 of the present invention and Comparative Examples 1 to 5 were placed at 40° C. and 60° C. for investigation, and the properties, initial adhesion and solubility of the samples were tested. The results are shown in Tables 6 to 8.
[0069] Table 6 Test results of thermal stability of various embodiments and comparative examples.
[0070] .
[0071] Table 7 Initial adhesion test results of thermal stability investigation of various embodiments and comparative examples.
[0072] .
[0073] The results in Tables 6 and 7 show that under the conditions of thermal stability investigation, the loxoprofen sodium patch prepared by the present invention has relatively stable sample properties, no significant differences in appearance, and the initial adhesion test results all meet the requirements.
[0074] Dissolution assay
[0075] Dissolution determination method: Cut the sample into circular slices with a diameter of 3.0 cm (where the release area is a circle with a diameter of 2.6 cm), peel off the protective layer and place it on a stainless steel plate with the paste side facing up and fixed with a stainless steel ring. Use 700 ml of sodium dodecyl sulfate solution (1→1000) as the dissolution medium, the temperature is 32°C, the rotation speed is 100 revolutions per minute, take samples for testing after 60 minutes, and calculate the dissolution rate.
[0076] Table 8 Dissolution test results of thermal stability study of examples and commercially available products.
[0077] .
[0078] The results show that the loxoprofen sodium patch prepared by the present invention has no significant change in dissolution under the high temperature test condition of 60° C., and has better thermal stability than the commercially available preparations.
[0079] Examples 9 to 16 are flurbiprofen patches, and the prescriptions are shown in Table 9 below.
[0080] Table 9 List of prescriptions for various examples.
[0081] .
[0082] The preparation methods of Examples 9 to 16 are:
[0083] According to the proportion of the components, SIS, polyisobutylene, hydrogenated rosin glycerol ester, and part of the liquid paraffin are heated until melted, butylated hydroxytoluene is optionally added, stirred evenly, and then flurbiprofen and the remaining liquid paraffin are added, and silicon dioxide and menthol are optionally added, and stirred evenly to obtain a paste;
[0084] The paste is evenly coated on the protective layer, and then laminated to the backing layer, and finally cut into a suitable size to obtain the flurbiprofen patch.
[0085] The prescription of comparative example is shown in the following table.
[0086] Table 10 List of prescriptions for comparative examples.
[0087] .
[0088] The preparation methods of Comparative Examples 6 to 10 are:
[0089] Heat SIS, polyisobutylene, butylated hydroxytoluene, hydrogenated rosin glycerol ester, and part of liquid paraffin until melted and stir evenly, then add flurbiprofen, the remaining amount of liquid paraffin, silicon dioxide, and menthol, stir evenly to obtain a paste;
[0090] The paste is evenly coated on the protective layer, and then laminated to the backing layer, and finally cut into a suitable size to obtain the flurbiprofen patch.
[0091] Adhesion test
[0092] The flurbiprofen patches prepared in Examples 9 to 16 of the present invention and Comparative Examples 6 to 10 were tested according to the following method.
[0093] Take this product, cut it into 5cm×10cm size, and stick it on the inclined surface of the adhesion tester with the adhesive surface facing up, keeping no gap between it and the thick paper. Set the part above the inclined surface that is more than 10cm away from the test product as the center of the ball, and operate according to the law (Chinese Pharmacopoeia 2015 Edition Part Four General Rules 0952 First Method). When the protective layer is quickly torn off, record the largest ball number that the adhesive surface can prevent from falling. Repeat the test 3 times, and the largest ball number that the adhesive surface can prevent from falling should be 19 or more.
[0094] Table 11 Initial adhesion test results of various embodiments and comparative examples.
[0095] .
[0096] Thermal stability test
[0097] The flurbiprofen patches prepared in Examples 9 to 16 of the present invention and Comparative Examples 6 to 10 were placed at 40° C. and 60° C. for investigation, and the properties, initial adhesion and solubility of the samples were tested. The results are shown in Tables 12 and 13.
[0098] Table 12 Test results of thermal stability of various embodiments and comparative examples.
[0099] .
[0100] Table 13 Initial adhesion test results of thermal stability investigation of various embodiments and comparative examples.
[0101] .
[0102] The results in Table 12 and Table 13 show that under the conditions of thermal stability investigation, the flurbiprofen patch prepared by the present invention has relatively stable sample properties, no significant differences in appearance, and the initial adhesion test results all meet the requirements.
[0103] Dissolution assay
[0104] Dissolution determination method: Cut the sample into circular slices with a diameter of 3.0 cm (where the release area is a circle with a diameter of 2.6 cm), peel off the protective layer and place it on a stainless steel plate with the paste side facing up and fixed with a stainless steel ring. Use 700 ml of sodium dodecyl sulfate solution (1→1000) as the dissolution medium, the temperature is 32°C, the rotation speed is 50 revolutions per minute, take samples for testing after 60 minutes, and calculate the dissolution rate.
[0105] Table 14 Dissolution test results of thermal stability study of examples and commercially available products.
[0106] .
[0107] The results show that the solubility of the flurbiprofen patch prepared by the present invention has no obvious change under the high temperature test condition of 60°C, and the thermal stability is better than that of the commercially available preparations.
[0108] Examples 17 to 24 are diclofenac sodium patches, and the prescriptions are shown in Table 15 below.
[0109] Table 15 List of prescriptions for various examples.
[0110] .
[0111] The prescription of comparative example is shown in the following table.
[0112] Table 16 List of prescriptions for each comparative example.
[0113] .
[0114] The preparation methods of Examples 17-24 and Comparative Examples 11-15 are:
[0115] According to the proportion of components, SIS, polyisobutylene, butylated hydroxytoluene, hydrogenated rosin glycerol ester, and liquid paraffin are heated and melted, stirred evenly, and then diclofenac sodium, dimethyl sulfoxide, menthol, silicon dioxide, and citric acid are added, stirred evenly, and a paste is obtained (components not in the prescription are not added);
[0116] The paste is evenly coated on the protective layer, and then bonded to the backing layer, and finally cut into a suitable size to obtain the diclofenac sodium patch.
[0117] Adhesion test
[0118] The diclofenac sodium patches prepared in Examples 17 to 24 of the present invention and Comparative Examples 11 to 15 were tested according to the following method.
[0119] Take this product, cut it into 5cm×10cm size, and stick it on the inclined surface of the adhesion tester with the adhesive surface facing up, keeping no gap between it and the thick paper. Set the part above the inclined surface that is more than 10cm away from the test product as the center of the ball, and operate according to the law (Chinese Pharmacopoeia 2015 Edition Part Four General Rules 0952 First Method). When the protective layer is quickly torn off, record the largest ball number that the adhesive surface can prevent from falling. Repeat the test 3 times, and the largest ball number that the adhesive surface can prevent from falling should be above 15.
[0120] Table 17 Initial adhesion test results of various embodiments and comparative examples.
[0121] .
[0122] Thermal stability test
[0123] The diclofenac sodium patches prepared in Examples 17 to 24 of the present invention and Comparative Examples 11 to 15 were placed at 40° C. and 60° C. for investigation, and the properties, initial adhesion and solubility of the samples were tested. The results are shown in Tables 18 and 19.
[0124] Table 18 Thermal stability test results of various embodiments and comparative examples.
[0125] .
[0126] Table 19 Initial adhesion test results of thermal stability investigation of various embodiments and comparative examples.
[0127] .
[0128] The results in Tables 18 and 19 show that under the conditions of thermal stability investigation, the diclofenac sodium patch prepared by the present invention has relatively stable sample properties, no significant differences in appearance, and the initial adhesion test results all meet the requirements.
[0129] Dissolution assay
[0130] Dissolution determination method: Cut the sample into circular slices with a diameter of 3.0 cm (where the release area is a circle with a diameter of 2.6 cm), peel off the protective layer and place it on a stainless steel plate with the paste side facing up and fixed with a stainless steel ring. Use 700 ml of sodium dodecyl sulfate solution (1→1000) as the dissolution medium, the temperature is 32°C, the rotation speed is 100 revolutions per minute, take samples for testing after 60 minutes, and calculate the dissolution rate.
[0131] Table 20 Dissolution test results of thermal stability study of examples and commercially available products.
[0132] .
[0133] The results show that the diclofenac sodium patch prepared by the present invention has no significant change in dissolution under the high temperature test condition of 60°C, and has better thermal stability than the commercially available preparations.
[0134] The above contents are further detailed descriptions of the present application in combination with specific implementation methods, and it cannot be determined that the specific implementation of the present application is limited to these descriptions. For ordinary technicians in the technical field to which the present application belongs, several simple deductions or substitutions can be made without departing from the concept of the present application, which should be deemed to fall within the scope of protection of the present application.
Claims
1. A hot-melt patch comprising a backing layer, an adhesive layer and a protective layer, characterized in that: In terms of weight percentage, the adhesive layer comprises: Active pharmaceutical ingredient 1~7%, Styrene-isoprene-styrene triblock copolymer 15~25%, Polyisobutylene 10~15%, Hydrogenated rosin glycerol ester 10~20%, Plasticizer 30~60%, Stabilizer silicon dioxide 0.5~3%, Wherein, the active ingredient of the drug is a nonsteroidal anti-inflammatory drug, and the weight ratio of styrene / isoprene in the styrene-isoprene-styrene triblock copolymer is 25 / 75; The melt index of the styrene-isoprene-styrene triblock copolymer is 9 g / 10 min; The softening point of the hydrogenated rosin glycerol ester is 80-120°C; The plasticizer is selected from liquid paraffin; The non-steroidal anti-inflammatory drug is selected from at least one of loxoprofen or a pharmaceutically acceptable salt thereof, flurbiprofen or a pharmaceutically acceptable salt thereof, and diclofenac or a pharmaceutically acceptable salt thereof.
2. The hot-melt patch according to claim 1, characterized in that It also includes at least one of an antioxidant, a penetration enhancer, a pH adjuster, an anti-irritant, and a solubility enhancer.
3. The hot-melt patch according to claim 1 or 2, characterized in that In terms of weight percentage, the amount of the stabilizer silicon dioxide is 0.5-2%.
4. The method for preparing the hot-melt patch according to any one of claims 1 to 3, characterized in that: The following steps are involved: Heat and melt styrene-isoprene-styrene triblock copolymer, polyisobutylene, hydrogenated rosin glycerol ester and part of plasticizer, optionally add antioxidant, stir evenly, then add active pharmaceutical ingredient, balance plasticizer and stabilizer silicon dioxide, optionally add cosolvent, pH adjuster, anti-irritant, penetration enhancer, stir evenly to obtain paste; The paste is evenly coated on the protective layer, then laminated to the backing layer, and finally cut into a suitable size to obtain a hot-melt patch.
